Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Positron emission tomography using F-18 fluorodeoxyglucose pre- and post-autologous stem cell transplant in non-Hodgkin's lymphoma

Bone Marrow Transplantation volume 41, pages 919–925 (2008)Cite this article

Abstract

Positron emission tomography (PET) utilizing fluorodeoxyglucose (FDG) has an ever-increasing role in the management of numerous malignancies. FDG PET in lymphoma is being incorporated into the response assessment in lymphoma as published by the Imaging Subcommittee of International Harmonization Project in Lymphoma. The exact role of FDG PET in non-Hodgkin's lymphoma (NHL) associated with autologous stem cell transplant (ASCT) is unclear. Numerous studies have identified pretransplant PET scans as being highly prognostic with regard to overall and PFS after ASCT. Many included a wide range of histologies, including Hodgkin's lymphoma and NHL. In studies with mixed histologies, PFS at 2 years has been improved by as much as 82% in patients with negative pre-ASCT PET scans. In studies incorporating only patients with NHL, improvements in failure-free survival have been reported as high as 43% for patients with negative pre-ASCT PET imaging. Limitations have included inclusion of many histologies, different reported time points, small retrospective studies and variation in the interpretation of a positive PET. Validation is ongoing in larger prospective trials. Future directions include the potential incorporation of post-ASCT therapy, such as radiation therapy or maintenance antibody therapy, for patients with positive pre-ASCT PET scans.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Moog F, Bangerter M, Diederichs CG, Guhlmann A, Kotzerke J, Merkle E et al. Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging. Radiology 1997; 203: 795–800.

    Article  CAS  Google Scholar 

  2. Moog F, Bangerter M, Diederichs CG, Guhlmann A, Merkle E, Frickhofen N et al. Extranodal malignant lymphoma: detection with FDG PET versus CT. Radiology 1998; 206: 475–481.

    Article  CAS  Google Scholar 

  3. Haioun C, Itti E, Rahmouni A, Brice P, Rain JD, Belhadj K et al. [18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcome. Blood 2005; 106: 1376–1381.

    Article  CAS  Google Scholar 

  4. Kostakoglu L, Coleman M, Leonard JP, Kuji I, Zoe H, Goldsmith SJ . PET predicts prognosis after 1 cycle of chemotherapy in aggressive lymphoma and Hodgkin's disease. J Nucl Med 2002; 43: 1018–1027.

    PubMed  Google Scholar 

  5. Spaepen K, Stroobants S, Dupont P, Vandenberghe P, Thomas J, de Groot T et al. Early restaging positron emission tomography with (18)F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma. Ann Oncol 2002; 13: 1356–1363.

    Article  CAS  Google Scholar 

  6. Juweid ME, Stroobants S, Hoekstra OS, Mottaghy FM, Dietlein M, Guermazi A et al. Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. J Clin Oncol 2007; 25: 571–578.

    Article  Google Scholar 

  7. Bondly C, Johnston PB, Lowe V, Ansell SM, Inwards DJ, Porrata LF et al. Positive positron emission tomography (PET) pre-autologous stem cell transplant (ASCT) in non-Hodgkin lymphoma (NHL) does not preclude successful outcome. Biol Blood Marrow Transplant 2006; 12: 18–19.

    Article  Google Scholar 

  8. Becherer A, Mitterbauer M, Jaeger U, Kalhs P, Greinix HT, Karanikas G et al. Positron emission tomography with [18F]2-fluoro-D-2-deoxyglucose (FDG-PET) predicts relapse of malignant lymphoma after high-dose therapy with stem cell transplantation. Leukemia 2002; 16: 260–267.

    Article  CAS  Google Scholar 

  9. Cremerius U, Fabry U, Wildberger JE, Zimny M, Reinartz P, Nowak B et al. Pre-transplant positron emission tomography (PET) using fluorine-18-fluoro-deoxyglucose (FDG) predicts outcome in patients treated with high-dose chemotherapy and autologous stem cell transplantation for non-Hodgkin's lymphoma. Bone Marrow Transplant 2002; 30: 103–111.

    Article  CAS  Google Scholar 

  10. Spaepen K, Stroobants S, Dupont P, Vandenberghe P, Maertens J, Bormans G et al. Prognostic value of pre-transplantation positron emission tomography using fluorine 18-fluorodeoxyglucose in patients with aggressive lymphoma treated with high-dose chemotherapy and stem cell transplantation. Blood 2003; 102: 53–59.

    Article  CAS  Google Scholar 

  11. Filmont JE, Czernin J, Yap C, Silverman DH, Quon A, Phelps ME et al. Value of F-18 fluorodeoxyglucose positron emission tomography for predicting the clinical outcome of patients with aggressive lymphoma prior to and after autologous stem-cell transplantation. Chest 2003; 124: 608–613.

    Article  Google Scholar 

  12. Svoboda J, Andreadis C, Elstrom R, Chong EA, Downs LH, Berkowitz A et al. Prognostic value of FDG-PET scan imaging in lymphoma patients undergoing autologous stem cell transplantation. Bone Marrow Transplant 2006; 38: 211–216.

    Article  CAS  Google Scholar 

  13. Filmont JE, Gisselbrecht C, Cuenca X, Deville L, Ertault M, Brice P et al. The impact of pre- and post-transplantation positron emission tomography using 18-fluorodeoxyglucose on poor-prognosis lymphoma patients undergoing autologous stem cell transplantation. Cancer 2007; 110: 1361–1369.

    Article  Google Scholar 

  14. Kassim A, Mineishi S, Greer J, Koyama T, Chinratanalab W, Brandt S et al. Post-transplant positron emission tomography using fluorine 18-fluor-deoxyglucose ([18F]FDG-PET) correlates with outcome in patients with aggressive non-Hodgkin's lymphoma undergoing high dose chemotherapy followed by autologous stem cell transplantation (HDC/ASCT). Blood 2004; 104: 259a.

    Google Scholar 

  15. Alousi A, Saliba R, Okoroji G, Hosing C, Samuels B, Champlin R et al. The influence of PET-gallium (PET/Gal) status and high-dose rituximab in patients with aggressive, large, b-cell lymphoma (LBCL) receiving autologous stem cell transplants. Blood 2006; 108: 3058a.

    Google Scholar 

  16. Schot BW, Zijlstra JM, Sluiter WJ, van Imhoff GW, Pruim J, Vaalburg W et al. Early FDG-PET assessment in combination with clinical risk scores determines prognosis in recurring lymphoma. Blood 2007; 109: 486–491.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Hematology/Blood and Marrow Transplantation, Mayo Clinic, Rochester, MN, USA

    P B Johnston & I N M Micallef

  2. Department of Nuclear Medicine, Mayo Clinic, Rochester, MN, USA

    G A Wiseman

Authors
  1. P B Johnston
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G A Wiseman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. I N M Micallef
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to P B Johnston.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Johnston, P., Wiseman, G. & Micallef, I. Positron emission tomography using F-18 fluorodeoxyglucose pre- and post-autologous stem cell transplant in non-Hodgkin's lymphoma. Bone Marrow Transplant 41, 919–925 (2008). https://doi.org/10.1038/bmt.2008.82

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2008.82

Keywords

This article is cited by

Search

Advanced search

Quick links